230 related articles for article (PubMed ID: 23451245)
1. Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies.
Ye X; Fu J; Yang Y; Chen S
PLoS One; 2013; 8(2):e57578. PubMed ID: 23451245
[TBL] [Abstract][Full Text] [Related]
2. Frequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysis.
Ye X; Fu J; Yang Y; Gao Y; Liu L; Chen S
PLoS One; 2013; 8(7):e71522. PubMed ID: 23936269
[TBL] [Abstract][Full Text] [Related]
3. Is aspirin use associated with a decreased risk of ovarian cancer? A systematic review and meta-analysis of observational studies with dose-response analysis.
Zhang D; Bai B; Xi Y; Wang T; Zhao Y
Gynecol Oncol; 2016 Aug; 142(2):368-77. PubMed ID: 27151430
[TBL] [Abstract][Full Text] [Related]
4. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
[No Abstract] [Full Text] [Related]
5. Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019.
Bosetti C; Santucci C; Gallus S; Martinetti M; La Vecchia C
Ann Oncol; 2020 May; 31(5):558-568. PubMed ID: 32272209
[TBL] [Abstract][Full Text] [Related]
6. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
7. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
[TBL] [Abstract][Full Text] [Related]
8. Sleep duration and cancer risk: a systematic review and meta-analysis of prospective studies.
Zhao H; Yin JY; Yang WS; Qin Q; Li TT; Shi Y; Deng Q; Wei S; Liu L; Wang X; Nie SF
Asian Pac J Cancer Prev; 2013; 14(12):7509-15. PubMed ID: 24460326
[TBL] [Abstract][Full Text] [Related]
9. Aspirin Use and Common Cancer Risk: A Meta-Analysis of Cohort Studies and Randomized Controlled Trials.
Wang L; Zhang R; Yu L; Xiao J; Zhou X; Li X; Song P; Li X
Front Oncol; 2021; 11():690219. PubMed ID: 34277434
[TBL] [Abstract][Full Text] [Related]
10. Aspirin dose and duration of use and risk of colorectal cancer in men.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Wu K; Fuchs CS
Gastroenterology; 2008 Jan; 134(1):21-8. PubMed ID: 18005960
[TBL] [Abstract][Full Text] [Related]
11. The association between coffee intake and breast cancer risk: a meta-analysis and dose-response analysis using recent evidence.
Li Y; Ma L
Ann Palliat Med; 2021 Apr; 10(4):3804-3816. PubMed ID: 33832295
[TBL] [Abstract][Full Text] [Related]
12. Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants.
Lu L; Shi L; Zeng J; Wen Z
Oncotarget; 2017 Jun; 8(25):40389-40401. PubMed ID: 28418881
[TBL] [Abstract][Full Text] [Related]
13. Intake of Non-steroidal Anti-inflammatory Drugs and the Risk of Prostate Cancer: A Meta-Analysis.
Shang Z; Wang X; Yan H; Cui B; Wang Q; Wu J; Cui X; Li J; Ou T; Yang K
Front Oncol; 2018; 8():437. PubMed ID: 30406025
[No Abstract] [Full Text] [Related]
14. Bisphosphonate use and risk of colorectal cancer: a systematic review and meta-analysis.
Bonovas S; Nikolopoulos G; Bagos P
Br J Clin Pharmacol; 2013 Sep; 76(3):329-37. PubMed ID: 23594375
[TBL] [Abstract][Full Text] [Related]
15. Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials.
Veettil SK; Lim KG; Ching SM; Saokaew S; Phisalprapa P; Chaiyakunapruk N
BMC Cancer; 2017 Nov; 17(1):763. PubMed ID: 29137605
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
17. Phyto-oestrogens and colorectal cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Jiang R; Botma A; Rudolph A; Hüsing A; Chang-Claude J
Br J Nutr; 2016 Dec; 116(12):2115-2128. PubMed ID: 28091359
[TBL] [Abstract][Full Text] [Related]
18. Is periodontal disease associated with increased risk of colorectal cancer? A meta-analysis.
Xuan K; Jha AR; Zhao T; Uy JP; Sun C
Int J Dent Hyg; 2021 Feb; 19(1):50-61. PubMed ID: 33269543
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
